Heart valve disease is a condition characterized by the malfunctioning of one or more of the heart's valves, which can impede the normal flow of blood through the heart chambers. The valves, including the aortic, mitral, tricuspid, and pulmonary valves, play a crucial role in ensuring unidirectional blood flow. Heart valve disease can result from congenital abnormalities, infections, age-related degeneration, or other acquired conditions. Common manifestations include valve stenosis (narrowing), regurgitation (leakage), or a combination of both. Individuals with heart valve disease may experience symptoms such as fatigue, shortness of breath, chest pain, and palpitations. Diagnosis involves imaging studies like echocardiography and may require further evaluation through cardiac catheterization or advanced imaging modalities. Treatment options vary depending on the severity and type of valve disease, ranging from medications to surgical interventions, such as valve repair or replacement, to restore proper cardiac function and improve the patient's quality of life.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya